News

Mr Posner’s career spans over 20 years in global finance positions in the healthcare industry. Most recently, Mr Posner served as executive vice president, and CFO with Pharmacopeia.

Mark Pulido, chairman of the board of Quidel, said: “I speak for the full board of directors of Quidel in recognizing Caren Mason for the outstanding leadership and

In this position, Mr Kurland will be responsible for directing Xoma’s financial strategy, accounting, financial planning and investor relations functions. Prior to joining Xoma, Mr Kurland served as

The patent broadly covers methods of treating obesity with combinations of bupropion and naltrexone, the two active agents in Contrave. It is a companion to the Weber/Cowley composition

As a result of these actions, Cigna expects to incur approximately $30-40 million, after tax, in cost reduction charges in the fourth quarter of 2008. The job eliminations

As part of this collaboration, PPD will be providing Merck with assay development and immunogenicity testing services to support Merck’s vaccine portfolio over a period of five years.

Dr Kirkpatrick has an extensive background in targeted small molecule cancer drug development, and has brought three agents from bench to bedside. Co-founder of ProlX Pharmaceuticals, Dr Kirkpatrick

This new center has 24 treatment stations and is currently caring for approximately 145 dialysis patients. The company is considering adding six more stations to the facility, which

Prism intends to submit a supplemental new drug application (NDA) for the premixed configurations which will form the focus of the commercial launch of Nexterone as a complete